During EBV-driven tumorigenesis, EBV replication during early lytic phase may facilitate an immune-suppressive tumor milieu (niche) via the chemotactic effect of CCL5 to attract monocytes, which further differentiate into tumor-associated macrophages (TAMs) [30]. This evidence concerns the gene CCL5 and neoplasm.